Incidence and risk of regorafenib-induced hepatotoxicity.

Oncotarget · 2017 · PMC5663580 · PMID 29137408

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

High-grade bilirubin, AST and ALT elevations also significantly increased, while high-grade ALP elevations showed a trend for increase for subjects exposed to regorafenib.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.